| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARDX | Common Stock | Options Exercise | $113,999 | +33,333 | +13% | $3.42 | 299,467 | 23 Jun 2023 | Direct | F1 |
| transaction | ARDX | Common Stock | Sale | $121,042 | -33,333 | -11% | $3.63 | 266,134 | 23 Jun 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARDX | Stock Option (Right to Buy) | Options Exercise | $0 | -33,333 | -100% | $0.000000* | 0 | 23 Jun 2023 | Common Stock | 33,333 | $3.42 | Direct | F1, F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction relates an option that would have expired on July 18, 2023 and does not result in a reduction of shares held outright by the Reporting Person. The shares acquired upon the exercise of the option were sold pursuant to a Rule 10b5-1 stock trading plan adopted by the Reporting Person on March 24, 2023. accordingly, the Reporting Person had no discretion with regard to the timing of the transaction. |
| F2 | This transaction was executed in multiple trades in prices ranging from $3.62 to $3.70, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F3 | The option, which was granted on July 18, 2013, and has an expiration date of July 18, 2023, is fully vested and exercisable. |
Chief Regulatory and Quality Affairs Officer